Newly published results showed spesolimab significantly impr

Newly published results showed spesolimab significantly improved signs and symptoms of flares in rare, life-threatening skin disease, generalized pustular psoriasis - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

New York , United States , Prnewswire Boehringer Ingelheim , Christopher Wahlers , Matt Frankel , Mark Lebwohl , Boehringer Ingelheim Pharmaceuticals , Ericj Waldman Department Of Dermatology , Boehringer Ingelheim Pharmaceuticals Inc , Boehringer Ingelheim , Drug Administration , Icahn School Of Medicine At Mount Sinai , Animal Health , Clinical Development , New England Journal , Clinical Therapeutics , Icahn School , Mount Sinai , Biologics License Application , Priority Review , Orphan Drug Designation , Breakthrough Therapy Designation , Vice President , Medical Affairs , Specialty Care , Global Assessment , Ingelheim Immunology , Pioneering Science , Human Pharma , Biopharmaceutical Contract , Ingelheim Pharmaceuticals , Resume , Careers , Ewly Published Results Showed Spesolimab Significantly Improved Signs And Symptoms Of Flares In Rare , Ife Threatening Skin Disease , Generalized Pustular Psoriasis , Iospace , Advice ,